- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nipro Corp (8086)
Nipro Corp stock price live, this page displays TYO 8086 stock exchange data. View the 8086 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nipro Corp real time stock price chart below.
What Is the Nipro Corp Stock Price Today?
The Nipro Corp stock price today is 1,446.5.
What Is the Stock Symbol for Nipro Corp?
The stock symbol for Nipro Corp is "8086."
What Stock Exchange Does Nipro Corp Trade On?
Nipro Corp is listed and trades on the Tokyo stock exchange.
Is Nipro Corp a Good Stock to Buy?
Determining whether Nipro Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 8086 quote. (ISIN: JP3673600007)
What Is the Nipro Corp Stock Price Today?
The Nipro Corp stock price today is 1,446.5.
What Is the Stock Symbol for Nipro Corp?
The stock symbol for Nipro Corp is "8086."
What Stock Exchange Does Nipro Corp Trade On?
Nipro Corp is listed and trades on the Tokyo stock exchange.
Is Nipro Corp a Good Stock to Buy?
Determining whether Nipro Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 8086 quote. (ISIN: JP3673600007)
Tokyo
Currency in JPY
1,446.5
+8.0(+0.56%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,430.0
1,448.5
52 wk Range
1,401.0
1,760.5
8086 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,430.01,448.5
52 wk Range
1,401.01,760.5
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.16%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.16%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
8086 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
1,996.0
Upside
+37.99%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Nipro receives FDA clearance for hemodialysis device- Investing.com
Nipro Corp receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Nipro receives FDA clearance for hemodialysis device
- Investing.com
- Nipro Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Nipro Corp receives Investment Bank Analyst Rating Update- Investing.com
Pro
Nipro Corp receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
2 Buy
3 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1,996.0
(+37.99% Upside)
Earnings
Latest Release
Aug 10, 2026
EPS / Forecast
23.48 / 8.12
Revenue / Forecast
167.55B / 167.17B
Compare 8086 to Peers and Sector
Metrics to compare | 8086 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship8086PeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.0x | 18.7x | −0.4x | |
PEG Ratio | 0.12 | 0.11 | 0.00 | |
Price/Book | 0.8x | 1.4x | 2.6x | |
Price / LTM Sales | 0.4x | 1.0x | 3.0x | |
Upside (Analyst Target) | 18.2% | 15.5% | 54.8% | |
Fair Value Upside | Unlock | 7.9% | 8.1% | Unlock |
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc. It also provides cardiopulmonary products comprising oxygenators, cardioplegia heat exchangers, perfusion tubing sets, arterial filters, hemoconcentrators, and venous and arterial cannulae; and enzymes, as well as contract development and manufacturing services. In addition, the company offers pharmaceutical combination products consisting of dual chamber bags, pre-filled syringes, and half-type kits; and integrated services, such as development, manufacturing, inspection, and packaging. Further, it provides glass containers, rubber stoppers, glass tubes, and other supplies for medical use; supplies for other industries; and drug administration systems, as well as autologous bone-marrow mesenchymal stem cells, culture products, and cell preservation products. The company was founded in 1947 and is headquartered in Settsu, Japan.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Nipro Corp (8086) Stock Price Today?
The Nipro Corp stock price today is 1,446.5 JPY.
What Stock Exchange Does Nipro Corp Trade On?
Nipro Corp is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Nipro Corp?
The stock symbol for Nipro Corp is "8086."
Does Nipro Corp Pay Dividends? What’s The Current Dividend Yield?
The Nipro Corp dividend yield is 2.16%.
What Is the Nipro Corp Market Cap?
As of today, Nipro Corp market cap is 239.1B JPY.
What Is Nipro Corp's Earnings Per Share (TTM)?
The Nipro Corp EPS (TTM) is 76.7.
When Is the Next Nipro Corp Earnings Date?
Nipro Corp will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is 8086 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Nipro Corp Stock Split?
Nipro Corp has split 3 times.
How Many Employees Does Nipro Corp Have?
Nipro Corp has 38593 employees.
What is the current trading status of Nipro Corp (8086)?
As of Sep 14, 2026, Nipro Corp (8086) is trading at a price of 1,446.5 JPY, with a previous close of 1,438.5 JPY. The stock has fluctuated within a day range of 1,430.0 JPY to 1,448.5 JPY, while its 52-week range spans from 1,401.0 JPY to 1,760.5 JPY.
What Is Nipro Corp (8086) Price Target According to Analysts?
The average 12-month price target for Nipro Corp is 1,996.0 JPY, with a high estimate of 2580 JPY and a low estimate of 1600 JPY. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +37.99% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.